Ipca Laboratories Ltd (IPCALAB) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow Ipca Laboratories Ltd reported sales of ₹2,788 Cr, operating profit of ₹670 Cr (OPM 24%) and net profit of ₹424 Cr for the quarter ended Jun 2026. Figures in ₹ crore, consolidated where available.
IPCALAB quarterly results (₹ Cr) Metric Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sales 2,355 2,245 2,247 2,309 2,556 2,392 2,388 2,788 Expenses 1,913 1,782 1,818 1,892 2,012 1,859 1,905 2,119 Operating Profit 441 463 429 416 545 533 484 670 OPM 19% 21% 19% 18% 21% 22% 20% 24% Other Income 26 20 -179 33 -30 38 48 25 Interest 23 17 22 19 20 18 20 12 Depreciation 100 98 100 100 103 108 107 111 Profit before tax 345 368 128 331 392 446 404 572 Tax 29% 25% 49% 29% 28% 18% 24% 26% Net Profit 246 276 64 233 281 364 307 424 EPS in Rs 9.05 9.78 2.67 9.19 11.14 12.86 11.79 15.84
IPCALAB profit & loss, annual (₹ Cr) Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM Sales 5,797 6,204 7,662 8,897 9,599 10,126 Expenses 4,472 5,272 6,338 7,166 7,609 7,894 Operating Profit 1,325 932 1,324 1,731 1,990 2,232 OPM 23% 15% 17% 19% 21% 22% Other Income 54 123 17 -114 80 81 Interest 11 48 141 88 79 69 Depreciation 232 262 357 398 418 429 Profit before tax 1,136 745 843 1,131 1,573 1,814 Tax 20% 34% 37% 30% 24% - Net Profit 890 479 523 785 1,184 1,375 EPS in Rs 34.85 18.58 21.57 29.08 44.98 51.63 Dividend Payout 11% 22% 19% 14% 0% -
IPCALAB balance sheet (₹ Cr) Metric Mar 2023 Mar 2024 Mar 2025 Sep 2025 Mar 2026 Equity Capital 25 25 25 25 25 Reserves 5,817 6,307 6,923 7,402 8,038 Borrowings 1,481 1,438 1,363 1,279 809 Other Liabilities 1,300 3,326 3,432 3,557 3,477 Total Liabilities 8,623 11,097 11,744 12,263 12,350 Fixed Assets 2,751 4,554 4,267 4,371 4,627 CWIP 140 343 622 777 773 Investments 626 862 980 1,203 844 Other Assets 5,105 5,339 5,875 5,912 6,106 Total Assets 8,623 11,097 11,744 12,263 12,350
IPCALAB cash flows (₹ Cr) Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Cash from Operating Activity 856 806 945 1,321 1,142 Cash from Investing Activity -851 -725 -1,215 -870 -247 Cash from Financing Activity 427 507 -553 -283 -754 Net Cash Flow 432 588 -823 169 142 Free Cash Flow 380 347 543 551 486 CFO/OP 80% 110% 94% 97% 78%
IPCALAB ratios Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Debtor Days 57 58 80 77 77 Inventory Days 337 276 350 336 353 Days Payable 101 83 110 111 122 Cash Conversion Cycle 293 251 321 302 308 Working Capital Days 102 71 111 101 109 ROCE 20% 11% 13% 15% 17%